Therapeutic innovation & regulatory science
Enhancing Safety Evaluations: A Comprehensive Framework for Evidence-Based Safety Assessment Using the Bradford Hill Criteria.
Anja Loos, Elian Khazneh, Jürgen Kübler
Published: 202610.1007/s43441-025-00910-y
Abstract
In drug development, safety assessments must integrate data from heterogeneous sources including clinical trials, non-clinical toxicology, mechanistic evidence, and real-world evidence. At any given timepoint-such as protocol development, dose escala…
Preview only. Read the full abstract at the source